By Andy Sambidge
Pfizer’s regional president of Worldwide Pharmaceuticals talks about the firm's new competitive strategy.
Like olympic gymnasts, every year the best companies get more agile. As the world’s largest drug maker, Pfizer is braced for change.
It has cut staff and recently, for the first time, revenues from outside the US overtook revenues from inside. Here, Dr Jorge Puente, Pfizer’s regional president of Worldwide Pharmaceuticals, talks about the company's new competitive strategy.